Table of Contents

September 8, 2005
Volume 48, Issue 18
Pages 5613-5874

About the Cover: Illustration of the binding mode of a biheteroaryl inhibitor to vascular endothelial growth factor receptor-2 (Kuo, G.-H.; et al. J. Med. Chem. 2005, 48, 1886-1900).

2005 American Chemical Society
A. C. Cope Award Address

Joys of Molecules. 2. Endeavors in Chemical Biology and Medicinal Chemistry

pp 5613–5638
Publication Date (Web): September 1, 2005 (Special Topics)
DOI: 10.1021/jm050524f

Letters

Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

pp 5639–5643
Publication Date (Web): August 6, 2005 (Letter)
DOI: 10.1021/jm050392q

4-Aryl-1,2,3-triazole:  A Novel Template for a Reversible Methionine Aminopeptidase 2 Inhibitor, Optimized To Inhibit Angiogenesis in Vivo

pp 5644–5647
Publication Date (Web): August 6, 2005 (Letter)
DOI: 10.1021/jm050408c

A Systematic Analysis of the Effect of Small-Molecule Binding on Protein Flexibility of the Ligand-Binding Sites

pp 5648–5650
Publication Date (Web): August 13, 2005 (Letter)
DOI: 10.1021/jm050276n

Enhancement of Aqueous Solubility and Stability Employing a Trans Acetate Axis in Trans Planar Amine Platinum Compounds while Maintaining the Biological Profile

pp 5651–5654
Publication Date (Web): August 17, 2005 (Letter)
DOI: 10.1021/jm050539d

The First de Novo-Designed Antagonists of the Human NK2 Receptor

pp 5655–5658
Publication Date (Web): August 11, 2005 (Letter)
DOI: 10.1021/jm050533o

Articles

Factorizing Selectivity Determinants of Inhibitor Binding toward Aldose and Aldehyde Reductases:  Structural and Thermodynamic Properties of the Aldose Reductase Mutant Leu300Pro−Fidarestat Complex

pp 5659–5665
Publication Date (Web): August 05, 2005 (Article)
DOI: 10.1021/jm050424+

Impact of Induced Fit on Ligand Binding to the Androgen Receptor:  A Multidimensional QSAR Study To Predict Endocrine-Disrupting Effects of Environmental Chemicals

pp 5666–5674
Publication Date (Web): August 13, 2005 (Article)
DOI: 10.1021/jm050403f

6,19-Sulfur-Bridged Progesterone Analogues with Antiimmunosuppressive Activity1

pp 5675–5683
Publication Date (Web): August 13, 2005 (Article)
DOI: 10.1021/jm049266x

6-Acylamino-2-aminoquinolines as Potent Melanin-Concentrating Hormone 1 Receptor Antagonists. Identification, Structure−Activity Relationship, and Investigation of Binding Mode

pp 5684–5697
Publication Date (Web): August 13, 2005 (Article)
DOI: 10.1021/jm050103y

Autocorrelation of Molecular Electrostatic Potential Surface Properties Combined with Partial Least Squares Analysis as New Strategy for the Prediction of the Activity of Human A3 Adenosine Receptor Antagonists

pp 5698–5704
Publication Date (Web): August 6, 2005 (Article)
DOI: 10.1021/jm0502440

Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of β-Amyloid1-42 Secretion

pp 5705–5720
Publication Date (Web): August 6, 2005 (Article)
DOI: 10.1021/jm0502541

Carbonic Anhydrase Inhibitors:  Stacking with Phe131 Determines Active Site Binding Region of Inhibitors As Exemplified by the X-ray Crystal Structure of a Membrane-Impermeant Antitumor Sulfonamide Complexed with Isozyme II

pp 5721–5727
Publication Date (Web): August 6, 2005 (Article)
DOI: 10.1021/jm050333c

Theoretical and Experimental Design of Atypical Kinase Inhibitors:  Application to p38 MAP Kinase

pp 5728–5737
Publication Date (Web): August 5, 2005 (Article)
DOI: 10.1021/jm050346q

Conformationally Constrained Analogues of Diacylglycerol (DAG). 25. Exploration of the sn-1 and sn-2 Carbonyl Functionality Reveals the Essential Role of the sn-1 Carbonyl at the Lipid Interface in the Binding of DAG-Lactones to Protein Kinase C

pp 5738–5748
Publication Date (Web): August 5, 2005 (Article)
DOI: 10.1021/jm050352m

E-Ring Modified Steroids as Novel Potent Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1

pp 5749–5770
Publication Date (Web): August 17, 2005 (Article)
DOI: 10.1021/jm050348a

Pharmacophore-Guided Drug Discovery Investigations Leading to Bioactive 5-Aminotetrahydropyrazolopyridines. Implications for the Binding Mode of Heterocyclic Dopamine D3 Receptor Agonists

pp 5771–5779
Publication Date (Web): August 11, 2005 (Article)
DOI: 10.1021/jm0503805

Design and Synthesis of Tricyclic Corticotropin-Releasing Factor-1 Antagonists

pp 5780–5793
Publication Date (Web): August 10, 2005 (Article)
DOI: 10.1021/jm049085v

4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as Non-Nucleoside Inhibitors of Human Cytomegalovirus and Related Herpesvirus Polymerases

pp 5794–5804
Publication Date (Web): August 9, 2005 (Article)
DOI: 10.1021/jm050162b

Modifications to the Tetracaine Scaffold Produce Cyclic Nucleotide-Gated Channel Blockers with Widely Varying Efficacies

pp 5805–5812
Publication Date (Web): August 13, 2005 (Article)
DOI: 10.1021/jm0502485

Synthesis and Structure−Activity Relationship of a Novel Series of Aminoalkylindoles with Potential for Imaging the Neuronal Cannabinoid Receptor by Positron Emission Tomography

pp 5813–5822
Publication Date (Web): August 6, 2005 (Article)
DOI: 10.1021/jm0502743

Novel Potent Antagonists of Transient Receptor Potential Channel, Vanilloid Subfamily Member 1:  Structure−Activity Relationship of 1,3-Diarylalkyl Thioureas Possessing New Vanilloid Equivalents

pp 5823–5836
Publication Date (Web): August 13, 2005 (Article)
DOI: 10.1021/jm0502790

Discovery of Potent, Nonsystemic Apical Sodium-Codependent Bile Acid Transporter Inhibitors (Part 1)

pp 5837–5852
Publication Date (Web): August 06, 2005 (Article)
DOI: 10.1021/jm040215+

Discovery of Potent, Nonsystemic Apical Sodium-Codependent Bile Acid Transporter Inhibitors (Part 2)

pp 5853–5868
Publication Date (Web): August 6, 2005 (Article)
DOI: 10.1021/jm0402162

Brief Articles

Cytostatic 6-Arylpurine Nucleosides. 6. SAR in Anti-HCV and Cytostatic Activity of Extended Series of 6-Hetarylpurine Ribonucleosides

pp 5869–5873
Publication Date (Web): August 9, 2005 (Brief Article)
DOI: 10.1021/jm050335x

Additions and Corrections

Synthesis and Biological Evaluation of Dimeric RGD Peptide−Paclitaxel Conjugate as a Model for Integrin-Targeted Drug Delivery.

p 5874
Publication Date (Web): August 10, 2005 (Addition/Correction)
DOI: 10.1021/jm058249k